Second-line Systemic Therapy Combined with SBRT for HCC with Oligoprogression After Standard First-line Systemic Treatment

Clinical trial NCT06592612 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06592612
Sponsor: Sun Yat-sen University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma Oligoprogression

Start date: 2024-10-01
Primary completion: 2026-10-31
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.